Omnia Biologics to provide vaccine services for Aeras

Published: 27-Jul-2006


US-based contract manufacturer Omnia Biologics is to supply the Aeras Global TB Vaccine Foundation Aeras with vaccine process and production services.

Omnia, located in Rockville, Maryland, is a provider of customised manufacturing services for the development of vaccines, gene-based drugs and biodefense products.

Aeras, also of Rockville, is attempting to develop one or more new vaccines against tuberculosis. The not-for-profit organisation would like to develop at least one new vaccine within the next decade.

Founded in 1997, Aeras received a five-year, US $82.9m grant from the Bill & Melinda Gates Foundation in 2004 for TB vaccine development. More recently, it got funding from the Centers for Disease Control and Prevention and the government of Denmark.

Aeras also has a new $10m lab and manufacturing facility in Rockville, which will be able to manufacture, in bulk, all of the developing world's needs for a new TB vaccine.

You may also like